Clinical impact of using [18F]AlF-NOTA-octreotide PET/CT instead of [68Ga]Ga-DOTA-SSA PET/CT: Secondary endpoint analysis of a multicenter, prospective trial.
Leupe H, Pauwels E, Vandamme T, Van den Broeck B, Lybaert W, Dekervel J, Van Herpe F, Jaekers J, Cleeren F, Hofland J, Brouwers A, Koole M, Bormans G, Van Cutsem E, Geboes K, Laenen A, Verslype C, Stroobants S, Deroose CM.
Leupe H, et al. Among authors: pauwels e.
J Neuroendocrinol. 2024 Jun 4:e13420. doi: 10.1111/jne.13420. Online ahead of print.
J Neuroendocrinol. 2024.
PMID: 38837825